Ovarian Cysts: Clinical Presentation and Pharmacologic Management

Ovarian cysts are a common gynaecological condition and may cause significant morbidity, including pain, infertility, or life-threatening complications such as rupture or torsion. Early recognition of symptoms and appropriate intervention are critical to preventing adverse outcomes. In many African healthcare settings, barriers such as limited access to specialized gynecological care, cultural stigma surrounding reproductive health, and low health literacy contribute to delayed diagnosis and treatment. Clinicians play a pivotal role in patient education, ensuring women understand the implications of ovarian cysts—including their potential impact on fertility and indications for surgical intervention.

This article delineates the clinical manifestations of ovarian cysts, explores pharmacologic strategies for symptom control and cyst resolution, and outlines circumstances in which surgical management becomes warranted.

1: Clinical Manifestations of Ovarian Cysts

Ovarian cysts may be incidental findings on imaging or present with varied symptomatology. Recognition of both subtle and acute presentations can guide timely diagnostic workup and treatment.

1.1 Common Symptoms

Symptom	Description
Pelvic or Abdominal Pain	Typically unilateral, described as dull or sharp,  intermittent or continuous, and often mistaken for dysmenorrhea or gastrointestinal discomfort.
Abdominal Distension or Bloating	Persistent sensation of fullness or increased girth, not attributable to dietary or gastrointestinal causes.
Menstrual Irregularities	Includes oligomenorrhea, menorrhagia, intermenstrual spotting, and dysmenorrhea, often linked to hormonal fluctuations.
Dyspareunia	Pain during deep vaginal penetration may be due to mass effect or cystic pressure on pelvic structures.
Urinary Frequency or Incomplete Emptying	Resulting from mechanical compression of the bladder, producing pelvic pressure or urgency.
Gastrointestinal Symptoms	Nausea and vomiting may indicate torsion or mass effect on adjacent organs.
Breast Tenderness	Hormonal shifts may cause mastalgia, similar to premenstrual symptomatology.
Fatigue and Malaise	Nonspecific, possibly related to hormonal imbalances or chronic discomfort.
Low Back Pain	May reflect posterior mass effect, radicular irritation, or referred pain from pelvic pathology.

1.2 Red Flags: Symptoms Suggesting Complications

Symptom	Possible Etiology
Sudden, Intense Pelvic Pain	Suggestive of ovarian torsion or cyst rupture—requires emergency assessment.
Fever	May signal infectious complications such as tubo-ovarian abscess or PID.
Tachypnoea and Dyspnea	Could indicate haemorrhage, peritonitis, or septic physiology.
Syncope, Hypotension,            Dizziness	Potential signs of acute blood loss or shock secondary to cyst rupture.
Signs of Haemoperitoneum	Includes pallor, diaphoresis, tachycardia, and hypotension—an immediate surgical emergency

Prompt evaluation is essential when these signs are present to prevent life-threatening sequelae.

2: Pharmacological Management

Treatment strategies depend on cyst type, symptom severity, and patient factors (e.g., fertility desires).

2.1 Hormonal Therapy: First-line treatment for recurrent functional cysts.

Combined Oral Contraceptives (COCs)

• Mechanism: Suppress ovulation, reducing new cyst formation.
• Examples: ethinyl estradiol + levonorgestrel, ethinyl estradiol + norgestimate.
• Adverse Effects: Nausea, thromboembolic risk (caution in smokers >35 years), mood changes.
• Evidence: Cochrane reviews support COCs in preventing recurrent cysts, though they do not accelerate resolution of existing cysts (Grimes et al., 2014).

Progestin-Only Options

• Alternatives for contraindicated patients (e.g., hypertension, migraine with aura).

2.2 Analgesia

NSAIDs (e.g., ibuprofen, naproxen):

• Preferred over paracetamol due to anti-inflammatory effects.
• Caution: GI ulcer risk with prolonged use.

2.3 GnRH Agonists (e.g., leuprolide)

• Indications: Refractory cysts, endometriosis-associated cysts.

• Side Effects: Hypoestrogenic symptoms (hot flashes, bone density loss).

• Considerations: Short-term use with add-back therapy if prolonged treatment is needed.

2.4 Antibiotics

• Required for infected cysts or tubo-ovarian abscesses.

• Empiric regimens: Doxycycline + metronidazole, or cephalosporins ± ampicillin-sulbactam.

3: Surgical Intervention

While pharmacologic approaches may suffice for many ovarian cysts, surgical intervention is sometimes required due to symptom severity, risk of malignancy, or failure of resolution.

3.1: Indications for Surgery

Surgical intervention is considered under the following circumstances:

• Cyst Size Exceeds Thresholds: Typically >5 cm, especially when associated with mechanical complications such as torsion, rupture, or compression of adjacent pelvic structures.
• Persistent Cyst: Lack of resolution despite several months of observation and medical therapy.
• Refractory Symptoms: Chronic or worsening pelvic pain impairing functional capacity, unresponsive to analgesics or hormonal therapy.
• Complication Development: Evidence of ovarian torsion, cyst rupture, or superimposed infection.
• Malignancy suspicion: Signs that a tumor might be cancerous include certain imaging features (like solid parts, divisions, or finger-like growths) or high levels of tumor markers (like CA-125).

Clinical Insight: Surgical intervention may provide definitive relief and facilitate histologic diagnosis, particularly in complex or suspicious cases.

3.2 Types of Surgical Approaches

1. Laparoscopy (Minimally Invasive Surgery)

Procedure: Utilizes small incisions for laparoscopic instrument access; a camera guides excision and retrieval of the cyst.

Indications: Ideal for benign, smaller cysts; preserves ovarian tissue and fertility.

Advantages:

• Reduced postoperative pain
• Minimal scarring
• Shorter hospital stay (often outpatient)
• Faster recovery (typically 1–2 weeks)

2. Laparotomy (Open Surgery)

Procedure: Involves a larger abdominal incision, allowing direct visualization and complete removal of the cystic mass and, if needed, adnexal structures.

Indications: Indicated for large, complex, or suspected malignant cysts.

Advantages:

• Facilitates extensive evaluation
• Safer for complex pathology

Drawbacks:

• Prolonged hospital admission
• Visible scarring
• Recovery typically spans 4–6 weeks

Fertility Considerations

Whenever feasible, surgical efforts aim to preserve ovarian function. In cases of significant damage or malignancy risk, oophorectomy (removal of the affected ovary) may be necessary. Discussions regarding fertility preservation should occur prior to surgery, particularly in younger patients.

Common Side Effects

Laparoscopy: Bloating, shoulder tip pain from CO₂ insufflation.

Recovery time usually 1-2 weeks

Laparotomy: Incisional discomfort, activity limitation. 

Recovery time usually 4-6 weeks

Complications:

• Wound infection
• Hemorrhage
• Injury to adjacent structures
• Pelvic adhesions

Follow-up Care:

• Repeat imaging (e.g., transvaginal ultrasound)
• Hormonal therapy if underlying PCOS or endometriosis
• Assessment for recurrence or residual symptoms